Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: Synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells

Inorganic Chemistry

Volumn 49, Issue 19, 2010, Pages 8790-8801

  Balakrishna, Maravanji S ^a   Suresh, D ^a   Rai, Ankit ^b   Mague, Joel T ^c   Panda, Dulal ^b  

^a Phosphorus Laboratory   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^c Tulane University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZIRIDINE DERIVATIVE; COPPER; LIGAND; ORGANOMETALLIC COMPOUND; PYRIDINE DERIVATIVE;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; CHO CELL; CRICETULUS; DRUG EFFECT; DRUG SCREENING; HAMSTER; HUMAN; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AZIRIDINES; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CHO CELLS; COPPER; CRICETINAE; CRICETULUS; CRYSTALLOGRAPHY, X-RAY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; PYRIDINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77957266917     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic100944d     Document Type: Article

References (62)

1. Clarke, M. J., Zhu, F., and Frasca, D. R. Chem. Rev. 1999, 99, 2511-2533
2. Mascini, M., Bagni, G., Pietro, M. L. D., Ravera, M., Baracco, S., and Osella, D. Biometals 2006, 19, 409-418
3. Farver, O. Textbook of Drug Design and Discovery, 3rd ed.; Taylor & Francis Ltd.: London, U.K., 2002; pp 364 - 409.
4. Guo, Z. and Sadler, P. J. Advances in Inorganic Chemistry; Academic Press: San Diego, CA, 2000; Vol. 49, pp 183 - 306.
5. Lippert, B. Cisplatin: Chemistry and biochemistry of a leading anticancer drug; Wiley-VCH: Weinheim, Germany, 1999.
6. Matsumoto, K. and Sakai, K. Advances in Inorganic Chemistry; Academic Press: San Diego, CA, 2000; Vol. 49, pp 375 - 427.
7. Ho, J. W. Recent Pat. Anti-Cancer Drug Discovery 2006, 1, 129-134
8. Ardizzoni, A., Antonelli, G., Grossi, F., Tixi, L., Cafferata, M., and Rosso, R. Ann. Oncol. 1991, 10, S13-S17
9. Kelland, L. R. Crit. Rev. Oncol. Hematol. 1993, 15, 191-219
10. Sadler, P. J. and Guo, Z. Pure Appl. Chem. 1998, 70, 863-871
11. Brewer, G. J. Exp. Biol. Med. 2001, 226, 665-673
12. Simon, T. M., Kunishima, D. H., Vibert, G. J., and Lober, A. Cancer Res. 1981, 41, 94-97
13. Berners-Price, S. J., Mirabelli, C. K., Johnson, R. K., Mattern, M. R., McCabe, F. L., Faucette, L. F., Sung, C. M., Sadler, P. J., and Crooke, S. T. Cancer Res. 1986, 46, 5486-5489
14. Pogozelski, W. K. and Tullius, W. K. Chem. Rev. 1998, 98, 1089-1107
15. Sigman, D. S., Bruce, T. W., and Sutton, C. L. Acc. Chem. Res. 1993, 26, 98-104
16. Zhang, S., Zhu, Y., Tu, C., Wei, H., Yang, Z., Lin, L., Ding, J., Zhang, J., and Guo, Z. J. Inorg. Biochem. 2004, 98, 2099-2106
17. Hegg, E. L. and Burstyn, J. N. Coord. Chem. Rev. 1998, 173, 133-165
18. An, Y., Liu, S.-D., Deng, S.-Y., Ji, L.-N., and Mao, Z.-W. J. Inorg. Biochem. 2006, 100, 1586-1593
19. Dillon, C. T., Hambley, T. W., Kennedy, B. J., Lay, P. A., Weder, J. E., and Zhou, Q. D. Met. Ions Biol. Syst. 2004, 41, 253-277
20. Weder, J. E., Dillon, C. T., Hambley, T. W., Kennedy, B. J., Lay, P. A., Biffin, J. R., Regtop, H. L., and Davies, N. M. Coord. Chem. Rev. 2002, 232, 95-126
21. Sorenson, J. R. J., Ramakrishna, K., and Rolniak, T. M. Agents Actions 1982, 12, 408-411
22. Muller, A. R., Vizcaya-Ruiz, A. D., Plant, N., Ruiz, L., and Dobrota, M. Chem.-Biol. Interact. 2007, 165, 189-199
23. Marzano, C., Pellei, M., Colavito, D., Alidori, S., Lobbia, G. G., Gandin, V., Tisato, F., and Santini, C. J. Med. Chem. 2006, 49, 7317-7324
24. Marzano, C., Pellei, M., Tisato, F., and Santini, C. Anti-Cancer Agents Med. Chem. 2009, 9, 185-211
25. Aplegot, S., Coppey, J., Fromentin, A., Guille, E., Poupon, M. F., and Roussel, A. Anticancer Res. 1986, 6, 159-165
26. Devereux, M., Shea, D. O., Kellett, A., McCann, M., Walsh, M., Egan, D., Deegan, C., Kedziora, K., Rosair, G., and Muller-Bunz, H. J. Inorg. Biochem. 2007, 101, 881-892
27. Sanghamitra, N. J., Phatak, P., Das, S., Samuelson, A. G., and Somasundaram, K. J. Med. Chem. 2005, 48, 977-985
28. Snyder, R. M., Mirabelli, C. K., Johnson, R. K., Sung, C. M., Faucette, L. F., McCabe, F. L., Zimmerman, J. P., Whiteman, M., Hempel, J. C., and Crooke, S. T. Cancer Res. 1986, 46, 5054-5060
29. Adwankar, M. K., Wycliff, C., and Samuelson, A. G. Indian J. Exp. Biol. 1997, 810-814
30. Berners-Price, S. J., Johnson, R. K., Mirabelli, C. K., Faucette, L. F., McCabe, F. L., and Sadler, P. J. Inorg. Chem. 1987, 26, 3383-3387
31. Berners-Price, S. J. and Sadler, P. J. Struct. Bonding (Berlin) 1988, 70, 27-102
32. Marzano, C., Pellei, M., Alidori, S., Brossa, A., Lobbia, G. G., Tisato, F., and Santini, C. J. Inorg. Biochem. 2006, 100, 299-304
33. Rankin, G. O. J. Toxicol. Environ. Health, Part B 2004, 46, 5486-5489
34. Phosphacreatine is a P-N-bond-containing compound synthesized in the liver and transported to the muscle cells for storage, which can readily generate ATP from ADP on demand within 2-7 s.
35. Priya, S., Balakrishna, M. S., Mague, J. T., and Mobin, S. M. Inorg. Chem. 2003, 42, 1272-1281
36. Balakrishna, M. S., Eisler, D., and Chivers, T. Chem. Soc. Rev. 2007, 36, 650-664
37. Suresh, D., Balakrishna, M. S., and Mague, J. T. Dalton Trans. 2008, 3272-3274
38. Chandrasekaran, P., Mague, J. T., and Balakrishna, M. S. Organometallics 2005, 24, 3780-3783
39. Chandrasekaran, P., Mague, J. T., and Balakrishna, M. S. Inorg. Chem. 2005, 44, 7925-7932
40. Chandrasekaran, P., Mague, J. T., and Balakrishna, M. S. Inorg. Chem. 2006, 45, 5893-5897
41. Chandrasekaran, P., Mague, J. T., and Balakrishna, M. S. Inorg. Chem. 2006, 45, 6678-6683
42. Chandrasekaran, P., Mague, J. T., and Balakrishna, M. S. Dalton Trans. 2009, 5478-5486
43. Chandrasekaran, P., Mague, J. T., Venkateswarn, R., and Balakrishna, M. S. Eur. J. Inorg. Chem. 2007, 4998-4997
44. Balakrishna, M. S., Venkateswarn, R., and Mague, J. T. Inorg. Chem. 2009, 48, 1398-1406
45. Balakrishna, M. S., Chandrasekaran, P., and Venkateswarn, R. J. Organomet. Chem. 2007, 692, 2642-2648
46. Balakrishna, M. S., Mague, J. T., and Chandrasekaran, P. Dalton Trans. 2007, 2957-2962
47. Suresh, D., Balakrishna, M. S., Rathinasamy, K., Panda, D., and Mobin, S. M. Dalton Trans. 2008, 2812-2814
48. Suresh, D., Balakrishna, M. S., Rathinasamy, K., Panda, D., and Mague, J. T. Dalton Trans. 2008, 2285-2292
49. Bond, A. D., Doyle, E. L., Garcia, F., Kowenicki, R. A., McPartlin, M., Riera, L., and Wright, D. S. Chem. Commun. 2003, 2990
50. Papazisis, K. T., Geromichalos, G. D., Dimitriadis, K. A., and Kortsaris, A. H. J. Immunol. Methods 1997, 208, 151-158
51. Mohan, R., Banerjee, M., Ray, A., Manna, T., Wilson, L., Owa, T., Bhattacharyya, B., and Panda, D. Biochemistry 2006, 45, 5440-5449
52. Mohan, R. and Panda, D. Cancer Res. 2008, 68, 6181-6189
53. Rathinasamy, K. and Panda, D. Biochem. Pharmacol. 2008, 76, 1669-1680
54. Rathinasamy, K. and Panda, D. FEBS J. 2006, 273, 4114-4128
55. Zhu, N. and Wang, Z. Anal. Biochem. 1997, 246, 155-158
56. APEX2, version 2.1-4; Bruker-AXS: Madison, WI, 2007.
57. SAINT+, version 7.34A; Bruker-AXS: Madison, WI, 2006.
58. Sheldrick, G. M. CELL-NOW; University of Göttingen: Göttingen, Germany, 2005.
59. Sheldrick, G, M. SADABS, version 2007/2; University of Göttingen: Göttingen, Germany, 2007.
60. Sheldrick, G. M. TWINABS, version 2007/2; University of Göttingen: Göttingen, Germany, 2007.
61. Sheldrick, G. M. SHELXS-97 and SHELXL-97; University of Göttingen: Göttingen, Germany, 1997.
62. Wyllie, A. H. Nature 1980, 284, 555-556